Skip to main content
FDA surveillance for medical device quality teams

From MAUDE reports to documented review.

DeviceWatch collects FDA reports for your product codes and prepares AI summaries for human review. Check the source evidence and record your team’s decisions with an audit trail.

14-day Growth trial. No credit card. $499/month after trial.

The problem

The data is growing faster than any team can read it

A large reporting dataset still needs careful interpretation and qualified review.

3.1M

adverse events reported to FDA in 2022

Source: Mishali et al., Digital Health, 2025

~8,600

adverse events a day in 2022, the same 3.1M spread over the year

Source: Mishali et al., Digital Health, 2025

1,059

device recalls in 2024, up 8.6% YoY

Source: UL Solutions, 2025

$2.5B–$5B

yearly industry cost of non-routine quality events like recalls

Source: McKinsey

Watch the 2-minute demo

See DeviceWatch work through a day of FDA reports

From raw FDA MAUDE narratives to reviewed, audit-ready intelligence — the whole pipeline in under two minutes.

DeviceWatch overview with fictional demonstration data
  1. 0:00The report-volume problem
  2. 0:35Automated MAUDE ingestion
  3. 0:47AI summaries + human review
  4. 1:11Signals, recalls & 510(k)
  5. 1:28Part 11 audit & one-click reports

Features

Monitor, analyze and act.

Tools for scheduled monitoring, qualified review and report preparation. Coverage stays visible throughout your team’s work.

How to read this: AI findings stay provisional until your team reviews them, and MAUDE counts cannot establish adverse-event rates or compare device safety.

1
Monitor

Monitor your product codes

Add your product codes once. DeviceWatch checks FDA MAUDE on a schedule and matches available records to your products. Coverage and freshness views show what has been collected and what still needs processing.

Review related device reports

Review reported problems for related devices alongside your own, and use them to frame questions for investigation.

More monitor capabilities (2)

Alerts with delivery status

Critical analyses enter a delivery queue for eligible email and webhook destinations. Delivery status shows retries and held attempts.

A digest of available analyses

Scheduled email digests list new reports for each monitored product, with severity counts from available analyses.

2
Analyze

Provisional summaries for human review

When a narrative is available and processed, AI extracts reported failure modes, severity and patient outcomes for your team to check against the source. Ongoing analysis covers Death and Injury reports; missing analysis and unknown findings stay visible.

Record your review decision

Your team can acknowledge, flag or reject analyzed records. Signed review actions record the reviewer, time and decision in the audit trail.

More analyze capabilities (2)

Explore patterns in collected records

Explore report counts, provisional severity findings and failure patterns in collected data, with collection and analysis coverage alongside.

Investigate signals in Compliance Pro

Compliance Pro surfaces configured volume and severity signals from available data for your team to investigate.

3
Act

PSUR drafts with a source trail

Compliance Pro assembles provisional periodic safety update reports from available analyses, trends and retained evidence.

Link investigations to source evidence

Compliance Pro links safety signals, investigation notes and CAPA actions to retained evidence, with every status change logged to the audit trail.

More act capabilities (2)

Reports with retained evidence

Generate provisional PDFs with retained evidence. Custom templates require Compliance Pro.

Your data, your workflows

Use the read-only REST API to retrieve available surveillance records for your own tools. Governed review decisions stay in DeviceWatch.

Inside DeviceWatch

See the evidence. Review the findings.

Product screens rendered with fictional demonstration data. The narrative and summary are illustrative, not a measured AI performance result.

Review the finding alongside its source.

Read the available summary and source narrative, then record a review. This fictional example uses a test fixture in place of an AI-generated analysis.

Event detail for a fictional pump report, showing an illustrative test summary, source narrative and review controls.View full-size event detail (new tab)

See what still needs your team’s review.

Check analysis coverage, scan provisional findings and open the source before recording a decision. FDA categories and AI severity stay distinct; unknown findings remain visible.

Needs review queue with one fictional pending pump record, unknown severity, filters and a source inspection link.View full-size review queue (new tab)

Bring one FDA product code. We’ll walk through the available records and analysis coverage with your team.

Book a 30-minute walkthrough

Built for regulated environments

Public FDA sources, handled with care

Source records come from public FDA datasets and keep their FDA report identifiers.

Signed, attributable review decisions

Signed reviews bind identity, meaning and server time to the action.

Hash-chained, tamper-evident audit trail

Governed record changes commit with their audit entries. Compliance Pro adds chain verification and audited exports.

Part 11 compliance rests on your validated procedures and intended use.

Workload scenario

Model your surveillance workload

Set your team's workload and an assumed reduction. See the time still needed for review and the subscription cost.

Starting values are examples, not customer results. Set your own team, hours and assumed reduction.

Growth covers up to 10 team members. For larger teams, discuss Compliance Pro with us.

This is your assumption, not a measured DeviceWatch result. The 90% limit keeps some reviewer effort in every scenario.

Baseline workload cost per year
$48,000
480 team hours per year at your hourly cost
Modeled capacity value per year
$12,000
120 team hours freed under your assumption
Remaining reviewer effort per year
360 hours
$36,000 of modeled team workload remains
Growth subscription per year
$5,988
$499 per month × 12 months
Net modeled capacity value after subscription
$6,012per year
Modeled capacity value minus the Growth subscription. Negative values mean the subscription costs more than the capacity modeled here. Freed time can be reassigned; it does not by itself reduce payroll.
For this workload, the subscription breaks even at an assumed reduction of 12.5%.

Pricing

Choose the workflow your team needs

14-day Growth trial. No credit card. Book a walkthrough to evaluate Compliance Pro.

Growth Trial

Growth

Competitor monitoring, severity and failure-mode analytics and provisional reports for your review.

$499/mo

or $4,990 a year (two months free)

  • 15 product codes
  • Competitor device tracking
  • Severity and failure-mode analytics (Death and Injury reports)
  • Team collaboration and signed reviews
  • Provisional trend reports
  • FDA recalls & 510(k) clearances
  • Slack and custom webhook alerts
  • PDF exports
  • Read-only REST API access
  • Hash-chained audit trail on every plan
  • Priority support
Start a free trial

Compliance Pro

Signal investigations, CAPA tracking, audit verification and provisional PSUR, PMS and CAPA summary reporting for qualified review.

$999/mo

or $9,990 a year (two months free)

  • Everything in Growth, plus
  • Unlimited product codes
  • Unlimited team members
  • Audit chain verification and audited exports
  • Safety signals & CAPA tracking
  • Provisional PSUR, PMS and CAPA summary reports
  • Custom report templates & branding
Book a Pro walkthrough

Enterprise

Single sign-on, validation support and contract terms for device makers whose quality and procurement teams need them.

$2,500+/mo
  • Everything in Compliance Pro
  • SSO/SAML + SCIM provisioning
  • IQ/OQ/PQ validation support package
  • Custom data retention
  • Database hosted in the US (AWS us-east-2)
  • Higher API limits + bulk export
  • Business-hours support with a named contact
  • Annual contract with MSA and DPA
Talk to sales

Founding customers: 30% off for 12 months for the first 10 manufacturers, in exchange for acting as a reference. Growth and Compliance Pro only.

Ask about founding pricing

Not ready for a trial? Get a weekly email for one product code when something changed. Monitor one code free

FAQ

Questions before you start

What exactly does DeviceWatch replace in our workflow?

DeviceWatch collects available FDA records on a schedule, queues narrative analysis and gives your team a review queue and report tools. Analysis coverage shows the records still waiting for processing. Your team checks the findings, records decisions and validates reports for their intended use.

How does the AI analysis work, and can we trust it?

Claude by Anthropic extracts failure modes, severity and other findings from clinical narratives. Ongoing analysis covers Death and Injury reports. When you add a product, its 20 most recent reports of any type are analyzed once. During a trial, analysis is limited to 25 reports a day. Each analysis enters a human review queue. Reports can include unreviewed or rejected analysis, so they remain provisional and state their coverage, review status and evidence limitations. Your qualified reviewers own the decisions.

Is this compliant with 21 CFR Part 11?

DeviceWatch provides role-based access, session timeouts, electronic signatures and a verifiable audit chain. Review decisions record identity and time. Report release commits the retained PDF, evidence and audit together; retained downloads are also audited. Part 11 compliance ultimately rests on your validated procedures and intended use.

Why would I track competitor devices?

Reports for related devices can help your team identify reported failure modes and questions to investigate. MAUDE is a reporting dataset, not a measure of device exposure. Its counts cannot establish adverse-event rates, compare device safety or prove that a device caused an event.

How much time will this actually save our team?

Time savings depend on the records you monitor and the review your team requires. DeviceWatch handles scheduled collection, analysis and report formatting. Coverage and review counts show the work still outstanding; your team validates the findings and decides how to use them. In the workload scenario, freed time can be reassigned but does not by itself reduce payroll, and setup and training time are not included.

We already have a QMS. How does this fit?

DeviceWatch supports the surveillance portion of your quality workflow: scheduled FDA record collection, provisional analysis, signed review and report preparation. Use exports or the read-only API to retrieve records for your existing tools. Your QMS and validated procedures remain part of the process.

What data sources does DeviceWatch monitor?

DeviceWatch ingests FDA MAUDE adverse-event records from openFDA and FDA bulk files, plus FDA recalls and 510(k) clearances through openFDA. Scheduled jobs match available records to your monitored products. Updates are periodic, not immediate. External notice collection also includes Health Canada recalls, FDA Early Alerts and FDA safety communications. Notice matches require human confirmation and coverage varies by source. These are public records; narrative content still requires appropriate handling.

How do you handle changes to FDA data sources?

DeviceWatch currently collects MAUDE records through openFDA and FDA bulk files, plus recalls and 510(k) records through openFDA. We monitor upstream data channels for changes. Check the in-app collection and analysis status when assessing what is available for your review.

Can I try it before committing?

Growth includes a 14-day free trial. No credit card required. For Compliance Pro features such as PSUR and PMS reports, book a walkthrough before choosing a paid plan. Add your product codes, and the most recent records for each are collected and queued for analysis (initial ingestion is capped per organization each hour, with analysis coverage shown in the app). Review the available records and workflow before deciding whether to subscribe.

The DeviceWatch brief

TrendWatch

A closer look at public device-safety records.

A free brief for RA/QA teams with public recall records, reported problems and questions for further review. See what’s inside →

Free, weekly. Unsubscribe in one click.

Start with one product code

Add a product code and review the records DeviceWatch collects for it. Growth is $499/month after a 14-day trial; no credit card is required to start.